A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I): Effects of prophylactic paracetamol on immunogenicity and reactogenicity of routine infant vaccines and 4CMenB

The novel meningococcal serogroup B vaccine (4CMenB, Bexsero(®)), recently approved in Europe and Australia, may soon be included in routine infant immunization schedules, subject to guidance from national or regional recommending bodies. In the development of 4CMenB and consistent with other newly...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Prymula, Roman, Esposito, Susanna, Zuccotti, Gian Vincenzo, Xie, Fang, Toneatto, Daniela, Kohl, Igor, Dull, Peter M
Médium: Artigo
Jazyk:Inglês
Vydáno: Landes Bioscience 2014
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4186040/
https://ncbi.nlm.nih.gov/pubmed/25424809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.28666
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky